Prognostic Stratification of Metastatic Prostate Cancer Patients Treated With Abiraterone and Enzalutamide Through an Integrated Analysis of Circulating Free microRNAs and Clinical Parameters

Androgen Receptor-Targeted Agents (ARTA) have dramatically changed the therapeutic landscape of metastatic Castration-Resistant Prostate Cancer (mCRPC), but 20–40% of these patients progress early after start of ARTA treatment. The present study investigated the potential utility of plasma cell-free...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharova, Evgeniya, Maruzzo, Marco, Del Bianco, Paola, Cavallari, Ilaria, Pierantoni, Francesco, Basso, Umberto, Ciminale, Vincenzo, Zagonel, Vittorina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009625/
https://www.ncbi.nlm.nih.gov/pubmed/33796462
http://dx.doi.org/10.3389/fonc.2021.626104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009625/
https://www.ncbi.nlm.nih.gov/pubmed/33796462
http://dx.doi.org/10.3389/fonc.2021.626104

Ejemplares similares